FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.8-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001066017 Concept inactivation indicator attribute value reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001067014 Concept inactivation indicator reference set en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001068016 Concept inactivation indicator attribute value reference set (foundation metadata concept) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


141007 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concept inactivation indicator reference set Is a Attribute value type true Inferred relationship Some

Members valueId
Acute/subacute ischaemic heart disease NOS Classification derived component
Acute/subacute ischemic heart disease NOS Classification derived component
Acute: [bronchitis] or [chest infections] or [tracheobronchitis] Ambiguous
Acute: [bronchitis] or [chest infections] or [tracheobronchitis] Ambiguous
Acute: [lymphadenitis] or [abscess lymph node] or [cervical adenitis] Ambiguous
Acyanotic congenital heart disease NOS Limited component (foundation metadata concept)
Acyclovir 200mg dispersible tablet A component that is no longer current, useful, appropriate or acceptable.
Acyclovir 200mg/5mL s/f suspension Ambiguous
Acyclovir 400mg dispersible tablet A component that is no longer current, useful, appropriate or acceptable.
Acyclovir 400mg tablet A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Acyclovir 800mg dispersible tablet A component that is no longer current, useful, appropriate or acceptable.
Acyclovir 800mg tablet A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Acyclovir sodium 1000mg powder A component that fails to comply with the current editorial guidance.
Acyclovir sodium 1000mg/20mL powder A component that fails to comply with the current editorial guidance.
Acyclovir sodium 500mg powder A component that fails to comply with the current editorial guidance.
Acyclovir sodium 500mg/10mL powder A component that fails to comply with the current editorial guidance.
Acyl-CoA synthase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Acylcarnitine + free carnitine A component that is no longer current, useful, appropriate or acceptable.
Acylsphingosine deacylase A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adactylia A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adaev horse breed Moved elsewhere
Adalat CC 60mg tablet Moved elsewhere
Adalimumab 40mg injection solution 0.8mL prefilled syringe Ambiguous
Adalimunab 40mg/mL injection solution 1mL prefilled syringe Ambiguous
Adamantinous craniopharyngioma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adamawa cattle breed Moved elsewhere
Adams operation on uterine ligaments A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adapalene A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adapalene - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adapalene 0.1% lotion Ambiguous
Adapalene 0.1% solution Ambiguous
Added in error: [FP22] or [GP22] Ambiguous
Added in error: [FP22] or [GP22] Ambiguous
Adder venom Ambiguous
Adderall XR 10mg capsule Moved elsewhere
Adderall XR 15mg capsule Moved elsewhere
Adderall XR 20mg capsule Moved elsewhere
Adderall XR 25mg capsule Moved elsewhere
Adderall XR 30mg capsule Moved elsewhere
Adderall XR 5mg capsule Moved elsewhere
Addison's disease Ambiguous
Addison's disease due to tuberculosis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Addison's disease, NOS Classification derived component
Addisonian crisis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Addisonian crisis A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Additional RAST test A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Additional behavior finding Ambiguous
Additional biochemical finding Limited component (foundation metadata concept)
Additional cardiovas observation Limited component (foundation metadata concept)
Additional chromosome NOS Limited component (foundation metadata concept)
Additional digest finding Limited component (foundation metadata concept)
Additional general conditions of patient Classification derived component
Additional mental state finding Limited component (foundation metadata concept)
Additional miscellaneous flaps A component that is no longer current, useful, appropriate or acceptable.
Additional neurologic observation Limited component (foundation metadata concept)
Additional preoperative procedure instituted by anesthetist Erroneous component (foundation metadata concept)
Additional preoperative therapy instituted by anesthetist Erroneous component (foundation metadata concept)
Additional respiratory observation Limited component (foundation metadata concept)
Additional swelling / lump observation Ambiguous
Additional urogenital observation Limited component (foundation metadata concept)
Address instruction Moved elsewhere
Address instruction Moved elsewhere
Addressing machine operator A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adduction test Ambiguous
Adearcoma Ambiguous
Aden Zebu cattle breed Moved elsewhere
Adenine phosphoribosyltransferase deficiency A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenocarcinoid tumor A component that is no longer current, useful, appropriate or acceptable.
Adenocarcinoid tumour A component that is no longer current, useful, appropriate or acceptable.
Adenocarcinoma and squamous carcinoma histologic grade A component that is no longer current, useful, appropriate or acceptable.
Adenocarcinoma in multiple adenomatous polyps A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenocarcinoma in situ in tubulovillous adenoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenocarcinoma in tubulovillous adenoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenocarcinoma of colon Ambiguous
Adenocarcinoma, no subtype A component that is no longer current, useful, appropriate or acceptable.
Adenocarcinoma, no subtype, high grade A component that is no longer current, useful, appropriate or acceptable.
Adenocarcinoma, no subtype, intermediate grade A component that is no longer current, useful, appropriate or acceptable.
Adenocarcinoma, no subtype, low grade A component that is no longer current, useful, appropriate or acceptable.
Adenofibroma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenofibroma, no International Classification of Diseases for Oncology subtype A component that is no longer current, useful, appropriate or acceptable.
Adenoid implantation Ambiguous
Adenoidectomy A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenoidectomy A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenoidectomy planned A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenoma and adenocarcinoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenoma of extrahepatic bile duct A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenoma, no subtype A component that is no longer current, useful, appropriate or acceptable.
Adenomatous goiter A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenomatous polyp of cervix A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenosarcoma A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenosine - chemical A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenosine 3mg/mL infusion solution 10mL vial A component that is no longer current, useful, appropriate or acceptable.
Adenosine 3mg/mL injection Ambiguous
Adenosine 3mg/mL injection solution 20mL vial A component that fails to comply with the current editorial guidance.
Adenosine 3mg/mL injection solution 2mL prefilled syringe A component that fails to comply with the current editorial guidance.
Adenosine 3mg/mL injection solution 2mL vial Ambiguous
Adenosine 3mg/mL injection solution 30mL vial A component that fails to comply with the current editorial guidance.
Adenosine 3mg/mL injection solution 4mL prefilled syringe A component that fails to comply with the current editorial guidance.
Adenosine 3mg/mL injection solution 4mL vial A component that fails to comply with the current editorial guidance.
Adenosine 5'-triphosphate A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adenosine agent A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 70 of 1411 Next End


Reference Sets

Reference set descriptor

Back to Start